Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Gadolinium-ethoxybenzyl-DTPA, a new liver-directed magnetic resonance contrast agent. Absence of acute hepatotoxic, cardiovascular, or immunogenic effects.

Mühler A, Clément O, Saeed M, Lake JR, Stites DP, Berthezène Y, Brasch RC.

Invest Radiol. 1993 Jan;28(1):26-32.

PMID:
8425849
2.
3.
4.

Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.

Benness G, Khangure M, Morris I, Warwick A, Burrows P, Vogler H, Weinmann HJ.

Invest Radiol. 1996 Apr;31(4):211-7.

PMID:
8721960
5.

Comparison of Gd-EOB-DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors.

Clemént O, Mühler A, Vexler VS, Kuwatsuru R, Berthezène Y, Rosenau W, Brasch RC.

J Magn Reson Imaging. 1993 Jan-Feb;3(1):71-7.

PMID:
8428104
6.

Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.

Benness G, Khangure M, Morris I, Warwick A, Burrows P.

Australas Radiol. 1993 Aug;37(3):252-5.

PMID:
8373327
7.

Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.

Schuhmann-Giampieri G, Frenzel T, Schmitt-Willich H.

Arzneimittelforschung. 1993 Aug;43(8):927-31.

PMID:
8216456
9.

Influence of gadolinium chelates on phosphorus-31 magnetic resonance spectroscopy of the liver.

Bauer H, Negishi C, Weinmann HJ.

Invest Radiol. 1994 Aug;29(8):752-7.

PMID:
7960625
10.

Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization.

Ni Y, Marchal G, Yu J, Mühler A, Lukito G, Baert AL.

J Magn Reson Imaging. 1994 May-Jun;4(3):355-63.

PMID:
8061434
11.

[Renal enhancement and excretion of the hepatobiliary contrast agent Gd-EOB-DTPA].

Zangos S, Hammerstingl R, Mack MG, Straub R, Engelmann K, Eichler K, Balzer T, Vogl TJ.

Rofo. 2001 Nov;173(11):1034-40. German.

PMID:
11704914
12.

Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.

Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB.

Acta Radiol. 2007 May;48(4):362-8.

PMID:
17453513
13.

Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.

Kiryu S, Inoue Y, Watanabe M, Izawa K, Shimada M, Tojo A, Yoshikawa K, Ohtomo K.

Magn Reson Imaging. 2009 Jan;27(1):101-7. doi: 10.1016/j.mri.2008.05.015. Epub 2008 Jul 3.

PMID:
18599243
14.
16.

Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA.

Yoshikawa K, Inoue Y, Akahane M, Shimada M, Itoh S, Seno A, Hayashi S.

J Magn Reson Imaging. 2003 Aug;18(2):204-9.

PMID:
12884333
17.

The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.

Shuter B, Tofts PS, Wang SC, Pope JM.

Magn Reson Imaging. 1996;14(3):243-53.

PMID:
8725190
18.

[A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].

Patrizio G, Pavone P, Cardone G, Pietroletti R, Passariello R, Tettamanti E, Musu C, Felder E.

Radiol Med. 1990 May;79(5):458-62. Italian.

PMID:
2359853
19.

Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.

Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U.

Radiology. 1992 Apr;183(1):59-64.

PMID:
1549695
20.

Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.

Brismar TB, Dahlstrom N, Edsborg N, Persson A, Smedby O, Albiin N.

Acta Radiol. 2009 Sep;50(7):709-15. doi: 10.1080/02841850903055603.

PMID:
19701821

Supplemental Content

Support Center